FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer.

Cancer Microenviron · 2013 · PMC3601218 · PMID 21732187

Europe PMC DOI

hedged sentence

0.0840

closest p · 1.7× alpha

0.0840

boldest claim

The sentences

showed a trendp = 0.084so close (0.05 < p ≤ 0.1)

Patients with high t-Foxp3+ cell counts compared to patients with low t-Foxp3+ counts showed a trend towards both a longer Overall Survival (OS) time (122 months vs. 96,7 months, p = 0.084) and a longer Disease Free Survival (DFS) time (109 months vs. 83 months, p = 0.073).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.